4//SEC Filing
Chadha Deepak 4
Accession 0001214659-20-002728
CIK 0000819050other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:30 PM ET
Size
15.5 KB
Accession
0001214659-20-002728
Insider Transaction Report
Form 4
Chadha Deepak
Chief Research & Dev. Officer
Transactions
- Award
Restricted Stock Units
2020-03-16$1.54/sh+25,000$38,500→ 25,000 totalExercise: $1.54From: 2021-03-16Exp: 2030-03-15→ Common Stock (25,000 underlying)
Holdings
- 10,356
Stock Options
Exercise: $12.17From: 2015-12-23Exp: 2025-12-23→ Common Stock (10,356 underlying) - 1,726
Stock Options
Exercise: $12.17From: 2016-06-07Exp: 2026-06-07→ Common Stock (1,726 underlying) - 5,178
Stock Options
Exercise: $16.69From: 2018-12-15Exp: 2027-12-15→ Common Stock (5,178 underlying) - 6,633
Warrants
Exercise: $10.36From: 2019-08-30Exp: 2029-08-30→ Common Stock (6,633 underlying) - 20,630
Common Stock
- 3,452
Stock Options
Exercise: $12.17From: 2015-09-01Exp: 2025-09-01→ Common Stock (3,452 underlying) - 1,726
Stock Options
Exercise: $12.17From: 2016-12-15Exp: 2026-12-15→ Common Stock (1,726 underlying) - 74,995
Stock Options
Exercise: $4.76From: 2020-08-30Exp: 2029-08-30→ Common Stock (74,995 underlying) - 25,891
Stock Options
Exercise: $16.45From: 2019-12-15Exp: 2028-12-15→ Common Stock (25,891 underlying)
Documents
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001784380
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:30 PM ET
- Size
- 15.5 KB